Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  2013-04-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00432-013-1421-5PMID 23552869PMCID PMC11824379
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma

  2011cited by this paper
• A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer

  2009cited by this paper
• PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/E-cadherin complexes in cancer cells.

  2008cited by this paper
• A snapshot of microarray-generated gene expression signatures associated with ovarian carcinoma

  2007cited by this paper
• Protein tyrosine phosphatases: from genes, to function, to disease

  2006cited by this paper
• Protein tyrosine phosphatases and signalling.

  2005cited by this paper
• Targeting Matrilysin and Its Impact on Tumor Growth In vivo: The Potential Implications in Breast Cancer Therapy

  2005cited by this paper
• Receptor-type Protein-tyrosine Phosphatase-κ Regulates Epidermal Growth Factor Receptor Function*

  2005cited by this paper
• Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.

  2005cited by this paper
• Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers

  2004cited by this paper
• Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer.

  2004cited by this paper
• Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer.

  2004cited by this paper
• Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas.

  2003cited by this paper
• Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas

  2003cited by this paper
• Mfold web server for nucleic acid folding and hybridization prediction

  2003cited by this paper
• Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas

  2003cited by this paper
• Estrogenic down-regulation of protein tyrosine phosphatase gamma (PTP gamma) in human breast is associated with estrogen receptor alpha.

  2002cited by this paper
• Identification of Protein-tyrosine Phosphatase 1B as the Major Tyrosine Phosphatase Activity Capable of Dephosphorylating and Activating c-Src in Several Human Breast Cancer Cell Lines*

  2000cited by this paper
• Expression of protein tyrosine phosphatase alpha (RPTPα) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivo

  2000cited by this paper
• Expression of protein tyrosine phosphatase alpha (RPTPalpha) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivo.

  2000cited by this paper
• 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.

  2000cited by this paper
• Leukocyte common antigen–related tyrosine phosphatase receptor: Increased expression and neuronal‐type splicing in breast cancer cells and tissue

  1999cited by this paper
• Roles of protein tyrosine phosphatases in cell migration and adhesion.

  1999cited by this paper
• Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.

  1999cited by this paper
• Targeted disruption of the tyrosine phosphatase PTPα leads to constitutive downregulation of the kinases Src and Fyn

  1999cited by this paper
• Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts.

  1999cited by this paper
• Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn.

  1999cited by this paper
• Transforming growth factor-beta1 inhibits human keratinocyte proliferation by upregulation of a receptor-type tyrosine phosphatase R-PTP-kappa gene expression.

  1996cited by this paper
• The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells.

  1996cited by this paper
• Transforming Growth Factor-β1 Inhibits Human Keratinocyte Proliferation by Upregulation of a Receptor-Type Tyrosine Phosphatase R-PTP-κ Gene Expression

  1996cited by this paper
• The Transmembrane Protein-tyrosine Phosphatase LAR Modulates Signaling by Multiple Receptor Tyrosine Kinases (*)

  1996cited by this paper
• Increased mRNA expression of the receptor-like protein tyrosine phosphatase α in late stage colon carcinomas

  1995cited by this paper
• Homophilic Interactions Mediated by Receptor Tyrosine Phosphatases μ and κ. A CRITICAL ROLE FOR THE NOVEL EXTRACELLULAR MAM DOMAIN (*)

  1995cited by this paper
• Regulation of the expression of E-cadherin on human cancer cells by gamma-linolenic acid (GLA).

  1995cited by this paper
• Regulation of the Expression of E-Cadherin on Human Cancer Cells by γ-Linolenic Acid (GLA)

  1995cited by this paper
• Increased mRNA expression of the receptor-like protein tyrosine phosphatase alpha in late stage colon carcinomas.

  1995cited by this paper
• Receptor tyrosine phosphatase R-PTP-kappa mediates homophilic binding

  1994cited by this paper
• Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression.

  1994cited by this paper
• Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.

  1993cited by this paper
• Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase

  1992cited by this paper
• Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21.

  1991cited by this paper
• Transforming Growth Factor (cid:2) (TGF- (cid:2) )-Smad Target Gene Protein Tyrosine Phosphatase Receptor Type Kappa Is Required for TGF- (cid:2) Function†

  year unknowncited by this paper

• Whole-genome resequencing reveals candidate genes and genetic mutations associated with colostrum yield in Hu sheep

  2026cites this paper
• Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models

  2025cites this paper
• Doxorubicin and topotecan resistance in ovarian cancer: Gene expression and microenvironment analysis in 2D and 3D models.

  2025cites this paper
• Protein tyrosine phosphatase receptor type kappa (PTPRK) revisited: evolving insights into structure, function, and pathology

  2025cites this paper
• Physical activity regulates the immune response to breast cancer by a hematopoietic stem cell-autonomous mechanism

  2023cites this paper
• Gene-environment analyses reveal novel genetic candidates with prenatal tobacco exposure in relation to risk for childhood acute lymphoblastic leukemia.

  2023cites this paper
• Comparative analysis of the occupancy of Histone H3 Lysine 4 methylation in the cells treated with TGFβ and Interferonγ.

  2023cites this paper
• R-PTP-κ Inhibits Contact-Dependent Cell Growth by Suppressing E2F Activity

  2022cites this paper
• CircRNA PTPRM Promotes Non-Small Cell Lung Cancer Progression by Modulating the miR-139-5p/SETD5 Axis

  2022cites this paper
• The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Doxorubicin and Topotecan Resistant Ovarian Cancer Cell Lines

  2022cites this paper
• The Non-Receptor Protein Tyrosine Phosphatase PTPN6 Mediates a Positive Regulatory Approach From the Interferon Regulatory Factor to the JAK/STAT Pathway in Litopenaeus vannamei

  2022cites this paper
• Piperine Targets Different Drug Resistance Mechanisms in Human Ovarian Cancer Cell Lines Leading to Increased Sensitivity to Cytotoxic Drugs

  2021cites this paper
• Protein tyrosine phosphatases in cell adhesion

  2021cites this paper
• Drug resistance evaluation in novel 3D in vitro model.

  2021cites this paper
• Effects of NRP1 on angiogenesis and vascular maturity in endothelial cells are dependent on the expression of SEMA4D

  2020cites this paper
• PTPRA facilitates cancer growth and migration via the TNF-α-mediated PTPRA-NF-κB pathway in MCF-7 breast cancer cells

  2020cites this paper
• Genetic characterization of a case of sellar metastasis from bronchial carcinoid neuroendocrine tumor

  2020cites this paper
• Gene Expression Along with Genomic Copy Number Variation and Mutational Analysis Were Used to Develop a 9-Gene Signature for Estimating Prognosis of COAD

  2020cites this paper
• OTT_A_255590 10393..10408

  2020cites this paper
• The tumor suppressor PTPRK promotes ZNRF3 internalization and is required for Wnt inhibition in the Spemann organizer

  2020cites this paper
• Hybrid Epithelial–Mesenchymal Phenotypes Are Controlled by Microenvironmental Factors

  2020cites this paper
• Chemical activation of divergent protein tyrosine phosphatase domains with cyanine-based biarsenicals

  2019cites this paper
• Downregulation of PTPRK Promotes Cell Proliferation and Metastasis of NSCLC by Enhancing STAT3 Activation

  2019cites this paper
• Etv6/Runx1 Fusion Gene Abrogation Decreases The Oncogenic Potencial Of Tumour Cells In A Preclinical Model Of Acute Lymphoblastic Leukaemia

  2019cites this paper
• AlloDriver: a method for the identification and analysis of cancer driver targets

  2019influential citation
• PTPRK suppresses progression and chemo‐resistance of colon cancer cells via direct inhibition of pro‐oncogenic CD133

  2019cites this paper
• Mutational impact of chronic alcohol use on stem cells in cirrhotic liver

  2019cites this paper
• PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations

  2019influential citation
• miRNA-627 inhibits cell proliferation and cell migration, promotes cell apoptosis in prostate cancer cells through upregulating MAP3K1, PTPRK and SRA1.

  2018influential citation
• Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling

  2018cites this paper
• Investigations of Leucine-rich repeats and immunoglobulin-like domain-proteins 1 and 2 (LRIG1 and LRIG2) and their genes in cancer

  2018cites this paper
• MiR-1260b promotes the migration and invasion in non-small cell lung cancer via targeting PTPRK.

  2018cites this paper
• Dual roles of protein tyrosine phosphatase kappa in coordinating angiogenesis induced by pro-angiogenic factors

  2017influential citation
• Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines

  2017cites this paper
• Pan-cancer screen for mutations in non-coding elements with conservation and cancer specificity reveals correlations with expression and survival

  2017cites this paper
• Genomic risk prediction of aromatase inhibitor‐related arthralgia in patients with breast cancer using a novel machine‐learning algorithm

  2017cites this paper
• Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification.

  2017cites this paper
• Utilising the MultiBac expression system to reconstruct and purify the gamma secretase enzyme

  2017cites this paper
• Phosphotyrosine profiling of curcumin-induced signaling

  2016cites this paper
• The Genome Conformation As an Integrator of Multi-Omic Data: The Example of Damage Spreading in Cancer

  2016cites this paper
• An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients

  2016cites this paper
• Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma.

  2015cites this paper
• Utilization of a canine cancer cell line (FACC) panel in comparative and translational studies of gene expression and drug sensitivity

  2015cites this paper
• Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysis.

  2015cites this paper
• Notch and TGF-β pathways cooperatively regulate receptor protein tyrosine phosphatase-κ (PTPRK) gene expression in human primary keratinocytes

  2015cites this paper
• Whole‐exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1

  2015cites this paper
• Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.

  2014cites this paper
• Original Article Knockdown of protein tyrosine phosphatase receptor U inhibits growth and motility of gastric cancer cells

  2014cites this paper
• Alterations in the Rat Serum Proteome Induced by Prepubertal Exposure to Bisphenol A and Genistein

  2014cites this paper
• Knockdown of protein tyrosine phosphatase receptor U inhibits growth and motility of gastric cancer cells.

  2014cites this paper
• Les thérapies anti-angiogéniques : entre espoir et réalité. Vers l'identification de marqueurs prédictifs et de nouvelles cibles thérapeutiques dans le traitement du cancer du rein

  2013cites this paper